271 results
·
16ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 3
×
Immunohistochemistry Assay, Antibody, Folr1
FDA Pre-Market Approval
FDA Class 3
·VENTANA FOLR1 (FOLR-2.1) RxDx Assay
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer
FDA Pre-Market Approval
FDA Class 3
·INFORM HER2 DUAL ISH DNA PROBE COCKTAIL
Kit, Dna Detection, Human Papillomavirus
FDA Pre-Market Approval
FDA Class 3
·COBAS HPV TEST
System, Test, Her-2/Neu, Ihc
FDA Pre-Market Approval
FDA Class 3
·PATHWAY anti-HER-2/neu (4B5) Rabbit Monoclonal Primary Antibody
Immunocytochemistry Assay, P16/Ki-67
FDA classification
FDA Class 3
·Immunocytochemistry Assay, P16/Ki-67
Wearable Automated External Defibrillator
FDA classification
FDA Class 3
·Wearable Automated External Defibrillator
Multi-Analyte Test System With Algorithmic Analysis For Detection Of Prostate Cancer
FDA Pre-Market Approval
FDA Class 3
·4Kscore Test
Implantable Cardioverter Defibrillator (Non-Crt)
FDA Pre-Market Approval
FDA Class 3
·GUARDIAN(R) ATP II IMPLANTABLE CARDIOVERTER/DIFIB.
System, Test, Her-2/Neu, Ihc
FDA Pre-Market Approval
FDA Class 3
·PATHWAY Anti-HER-2/neu (4B5) Rabbit Monoclonal Primary Antibody
Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions
FDA Pre-Market Approval
FDA Class 3
·FPSA FLEX REAGENT CARTRIDGE
System, Test, Her-2/Neu, Ihc
FDA Pre-Market Approval
FDA Class 3
·PATHWAY anti-HER-2/neu (4B5) Rabbit Monoclonal Primary Antibody
Total, Prostate Specific Antigen (Noncomplexed & Complexed) For Detection Of Prostate Cancer
FDA Pre-Market Approval
FDA Class 3
·DIMENSION VISTA TPSA FLEX REAGENT CARTRIDGE
Implantable Cardioverter Defibrillator (Non-Crt)
FDA Pre-Market Approval
FDA Class 3
·RES-Q(TM) ARRHYTHMIA CONTROL DEVICE EPICARDIAL PATCH AND NON-THORACOTOMY LEAD (NTL) SYSTEMS
Processor, Cervical Cytology Slide, Automated
FDA classification
FDA Class 3
·Processor, Cervical Cytology Slide, Automated
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer
FDA classification
FDA Class 3
·Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer
Implant, Cochlear
FDA Pre-Market Approval
FDA Class 3
·SONATATI100 COCHLEAR IMPLANT
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·VENTANA PD-L1(SP142) Assay.
Optoacoustic Imaging System
FDA Pre-Market Approval
FDA Class 3
·Imagio® Breast Imaging system
Optoacoustic Imaging System
FDA Pre-Market Approval
FDA Class 3
·Imagio Breast Imaging System
Implantable Cardioverter Defibrillator (Non-Crt)
FDA Pre-Market Approval
FDA Class 3
·PHYLAX IMPLANTABLE CARDIOVERTER DEFIBRILLATOR SYSTEM